ArticleAdvances in therapy2023

Real-World Hemoglobin A1c Changes, Prescribing Provider Types, and Medication Dose Among Patients with Type 2 Diabetes Mellitus Initiating Treatment with Oral Semaglutide.

Monica Frazer et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.